GUIDANT ACS Rx MULTI-LINK HAS 70% U.S. STENT MARKET DOLLAR VOLUME; EVEREST MEDICAL ATTRIBUTES 10% OF FOURTH-QUARTER VOLUME TO GUIDANT VASOVIEW BUSINESS
This article was originally published in The Gray Sheet
Executive Summary
Sales of Guidant's ACS Rx Multi-Link stent, launched on Oct. 2, topped $200 mil. in the fourth quarter of 1997, the company reported Feb. 3. According to Guidant President and CEO Ronald Dollens, who spoke the same day at a Piper Jaffray investor conference in New York City, the product now accounts for roughly 70% of the dollar volume and 60% of the unit volume of a U.S. stent market that is rapidly approaching an estimated $1 bil.